Compare QS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QS | RGEN |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.1B |
| IPO Year | 2020 | 1995 |
| Metric | QS | RGEN |
|---|---|---|
| Price | $5.96 | $111.82 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $8.40 | ★ $175.64 |
| AVG Volume (30 Days) | ★ 8.9M | 834.9K |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.15 | ★ 286.96 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | N/A | $14.31 |
| Revenue Next Year | $1,827.70 | $14.41 |
| P/E Ratio | ★ N/A | $128.20 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $3.40 | $102.97 |
| 52 Week High | $19.07 | $175.77 |
| Indicator | QS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 31.18 | 32.82 |
| Support Level | $4.21 | N/A |
| Resistance Level | $7.21 | $130.56 |
| Average True Range (ATR) | 0.32 | 4.57 |
| MACD | 0.01 | 0.42 |
| Stochastic Oscillator | 4.70 | 13.32 |
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.